Ekaterina Vladimirovna Anufrieva

Ekaterina Vladimirovna Anufrieva

Auto-generated profile, based on publicly available information

Ekaterina Vladimirovna Anufrieva

Saint Petersburg Pasteur Institute, 197101 St. Petersburg, Russia

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 October 2023 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
EAE. V. Anufrieva
E. V. Anufrieva
ESElena Николаевна Serikova
Elena Николаевна Serikova
YOYulia Ostankova
Yulia Ostankova
ASAlexandr Shchemelev
Alexandr Shchemelev
VDVladimir Davydenko
Vladimir Davydenko
ATAreg Artemovich Totolian
Areg Artemovich Totolian
The aim of the study was to assess the occurrence of serological and molecular genetic markers of HIV infection, viral hepatitis B and C among persons in pre-trial detention.Materials and methods. The material of the study identified 138 samples of blood sequences obtained from men in the pretrial detention center in St. Petersburg. Patients were examined by ELISA for the presence of serological markers of HIV infection (Ag/Ab HIV), HBV (HBsAg, antiHBs IgG, anti-HBcore IgG) and HCV (anti-HCV IgG). Determination of HIV and HCV RNA, as well as HBV DNA by PCR with hybridization-fluorescence detection in «real time» mode. HBV DNA with a low viral form was detected using a technique developed at the Saint-Petersburg Pasteur Institute.Results and discussion. With the prevalence of the general prevalence of serological markers, markers of HIV infection were detected in 55 (39.86%) patients, HBV — in 73 (52.90%), HCV — in 83 (60.14%). the same markers of HIV infection and HBV were detected in 6 (4.35%) examined, HIV infection and HCV in 17 (12.32%), HBV and HCV in 22 (15.94%) persons, to all three infections in 26 (18.84%) cases. In 22 (15.94%) people did not notice any of the analyzed markers. HIV RNA was found in 23.19%, HCV RNA — in 46.38%, HBV DNA — in 10.14% of the examined. At the same time, HBV DNA with a low viral form (less than 50 IU/ml) was detected in 7.97% of cases, including 6.52% of seronegative samples. Simultaneously, HIV and HCV RNA were detected in 6.52%, HCV RNA and HBV DNA in 2.17% of patients. Molecular biological markers of all three indicators were found in 1.45% of patients. The examined group was ranked by age into the following subgroups: 21– 30 years old (12.32%), 31–40 years old (34.78%), 41–50 years old (37.68%) and older than 51 years old (15.22%). Certain differences in the prevalence and distribution of the analysis of serological and molecular biological markers between age markers, the highest frequency was found for groups of 31–40 and 41–50 years.Conclusion. The results obtained indicate a high prevalence of HIV infections and parenteral viral hepatitis B and C among persons convicted and awaiting a stage in a pre-trial detention center. Careful attention must be paid to their admission to penitentiary institutions, since many convicts are not aware of their morbidity and may become infected. Regular conclusions, concluded in dynamics, including laboratory diagnostics using highly sensitive molecular biological methods, upon admission to a penitentiary institution, and then annually and upon release, should be taken into account as measures to prevent infection with HIV, HBV, HCV.

17 January 2024 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
DRD. E. Reingardt
D. E. Reingardt
YOYulia Ostankova
Yulia Ostankova
LLLiudmila V Lyalina
Liudmila V Lyalina
EAE. V. Anufrieva
E. V. Anufrieva
ASAleksandr Vladimirovich Semenov
Aleksandr Vladimirovich Semenov
ATAreg Artemovich Totolian
Areg Artemovich Totolian
The aim of the study was to identify the prevalence of drug resistance mutations in the hepatitis C virus among patients with relapse of the disease on therapy with direct antiviral drugs.Materials and methods. The study material included 31 blood plasma samples from patients with chronic hepatitis C with relapse of the disease on therapy with direct antiviral drugs. Samples were screened for the presence of HCV RNA. In case of detection of HCV RNA, amplification was carried out using a set of primers jointly flanking the NS3, NS5A, NS5B genes. After sequencing the nucleotide sequences of these genes, the subtype of the virus was determined and drug resistance mutations were identified.Results and discussion. The age of the patients ranged from 33 to 62 and averaged 45.8±8.38 years. The number of men in the group prevailed compared to women — 21 (67%) and 10 (33%), respectively. Viral load determination results ranged from 3.1×103 to 4.2×107 IU/ml. The distribution of genotypes was as follows: 1a — 26% (n=8), 1b — 29% (n=9), 3a — 45% (n=14). The nucleotide sequence of the NS3, NS5A, NS5B regions was determined in all samples. Mutations associated with drug resistance were detected in 87% (n=27). In all identified cases, the mutations resulted in viral resistance to at least one drug included in the patient’s current treatment regimen. In one patient, amino acid substitutions were found in three regions at once, which led to the emergence of resistance to two drugs in the regimen.Conclusion. Conducting a preliminary examination of patients to identify mutations of drug resistance to direct antiviral drugs can affect the effectiveness of the planned treatment and the choice of the optimal regimen.

13 February 2025 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
VDVladimir Davydenko
Vladimir Davydenko
YOYulia Ostankova
Yulia Ostankova
ASAlexandr Shchemelev
Alexandr Shchemelev
EAE. V. Anufrieva
E. V. Anufrieva
VKV. V. Kushnareva
V. V. Kushnareva
ATAreg Artemovich Totolian
Areg Artemovich Totolian
The aim of the study was to search for candidate genes interacting with HIV attachment receptors (CCR5, CXCR4, CCR2, CD4) and potentially involved in disease pathogenesis, based on complex in silico network algorithms.Materials and methods. A number of web applications were used to analyse genetic and protein-protein networks, the algorithms and databases of which are complementary. The CD4 receptor and chemokine co-receptor genes CCR5, CXCR4 and CCR2 were used as background/baseline genes in all cases, as their protein products play a key role in the process of virus attachment to the cell. The data were analysed, including a two-stage ranking of the identified candidate genes according to their interaction with background genes and their presence in the results of network analysis of different web resources.Results and discussion. According to the results, candidate genes were identified using three web resources: HumanNet — 451 candidate genes, GeneMania — 86, STRING — 61. Based on the results of crossing the three web resources, the total number of candidate genes associated with background genes was 511. The total number of genes with a rank above 4 points was 68. Of these, 31 genes (45.6%) encoding C-C/C-X-C family chemokine ligands, 12 genes (17.6%) encoding C-C/C-XC receptors, 8 genes (11.8%) encoding receptors of other types, and 17 genes (25%) encoding proteins of other types. The following receptors and proteins that are not members of the C-C/C/C-X-C families of the indicated groups have been identified: ARRB2, TLR2, ADRA1A, ARRB1, FPR1, FPR3, GNAI1, PF4, PIK3CG, PPIA, S1PR3, GNA11, GNAI2, GNG2, PTPRC, ADRA1B, ADRB1, AFP, CD164, DBN1, GNB1, ITCH, RNF113A, SLC1A1, USP14.Conclusion. Most of the identified candidate genes interacting with HIV attachment receptors and potentially involved in the pathogenesis of the disease were those encoding chemokine receptors and their C-C/C-X-C family ligands, the role of which in the progression of HIV infection is known or under active investigation. At the same time, genes whose products have never been considered as possible participants in the pathogenesis of the disease were identified, but the results suggest that they may play a role in the regulation of virus entry and/or in the modulation of the immune response of the organism. Further bioinformatic and experimental studies of the functions and polymorphic variants of these genes will help to improve the understanding of the genetic basis of HIV pathogenesis and identify new directions for therapeutic approaches.

28 November 2024 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
ESElena Николаевна Serikova
Elena Николаевна Serikova
YOYulia Ostankova
Yulia Ostankova
EAE. V. Anufrieva
E. V. Anufrieva
DRD. E. Reingardt
D. E. Reingardt
ASAlexandr Shchemelev
Alexandr Shchemelev
ATAreg Artemovich Totolian
Areg Artemovich Totolian
The aim of our study was to assess the prevalence of serological and molecular biological markers of parenteral viral hepatitis B and C among international migrants in the North-West Federal District (NWFD).Materials and methods. The study included 537 blood plasma samples obtained from foreign nationals from 46 countries who underwent medical examination to obtain a work permit in the Migration Department of the North-West Federal District. We assayed for the presence of serological (anti-HCV IgG, HBsAg, anti-HBs IgG, anti-HBs IgG) and molecular biological (HCV RNA, HBV DNA) markers.Results and discussion. More than 80% of the examined citizens belonged to 11 out of 46 represented countries. The analysis revealed 6.1% of persons with anti-HCV IgG antibodies and 2.6% with HBsAg. HCV RNA and HBV DNA were detected in 2.79% and 8.19%, respectively. Among HCV RNA-positive individuals, four (0.74%) were undetectable for anti-HCV. 6.15% of HBsAg-negative hepatitis B patients were detected. The contribution of migrants’ countries of origin to the frequencies of serological and molecular biological markers of hepatitis B and C identified in the surveyed group is discussed.Conclusion. The study of migration processes and associated flows of socially significant infections plays a key role in controlling the spread of infectious diseases on the territory of the Russian Federation, including the strengthening of the Russian Federation’s strategy for the elimination of viral hepatitis.

20 July 2023 in HIV Infection and Immunosuppressive Disorders
Verified
Journal Article
Open access
PDF file
TBT.A.L. Balde
T.A.L. Balde
ASA. N. Shchemelev
A. N. Shchemelev
YOYulia Ostankova
Yulia Ostankova
SBS. Boumbaly
S. Boumbaly
DVDiana Valutite
Diana Valutite
СБС. Бумбали
С. Бумбали
The aim of this study was to assess the prevalence and study of the molecular genetic characteristics of the human immunodeficiency virus in pregnant women of the Republic of Guinea.Materials and methods. The material for the study was blood plasma samples of 972 pregnant women from the Republic of Guinea. The patients were examined for the presence of HIV infection serological (Ag+Ab) and molecular markers (RNA). For patients with a positive PCR result and a sufficient viral load (>500 c/ml), the genetic sequences of the pol gene fragment responsible for the synthesis of pro and rev proteins were obtained by Sanger sequencing. These sequences were used for phylogenetic analysis and examined for drug resistance mutations.Results and discussion. 12.96% of patients was positive in ELISA. Among women who were positive in ELISA, RNA was detected in 76.98% of cases, however, in 11 cases, RNA was detected in patients without serological markers of HIV infection, so the incidence of HIV RNA in the entire surveyed population was 11.11%. In the vast majority of cases, the circulating recombinant form 02_AG is found. Based on the analysis, we assume a significant contribution of recombinant forms of HIV to the genetic diversity of the virus in the region under study.The incidence of DR mutations was quite high (26.80%). The most frequent substitutions were in position 20 of the protease (70.10%, 95% CI 59.96–78.98%), of which the K20I mutation was dominant. In addition, the L10I/V mutation was relatively common, increasing the replication of viruses with other PI resistance mutations. Among the mutations associated with HIV resistance to NNRTIs, a non-polymorphic mutation V179T was found.Conclusion. An important factor influencing the effectiveness of Prevention of Mother to Child Transmission identified in this study was the high prevalence of PDR among pregnant women in Guinea. The high prevalence of drug resistance mutations found in this study in pregnant women, as well as in ART-naive women, indicates that current regimens in Guinea are insufficient to prevent vertical HIV infection.

21 July 2025 in Problems of Virology
Verified
Journal Article
Open access
PDF file
EAEkaterina V. Anufrieva
Ekaterina V. Anufrieva
YOYulia Ostankova
Yulia Ostankova
VDVladimir Davydenko
Vladimir Davydenko
ASAlexandr Shchemelev
Alexandr Shchemelev
ATAreg Artemovich Totolian
Areg Artemovich Totolian
Aim. The aim of this study was to search for human genes potentially involved in the pathogenesis of hepatitis C by multi-network bioinformatics linkage analysis of proteins involved in the stages of hepatitis C virus (HСV) attachment and entry. Materials and methods. A number of web applications with complementary algorithms and databases were used to analyze genetic and protein-protein networks. The following genes were used as basic genes: CD81, CLDN1, LDLR, OCLN, SCARB1, the products of which are involved in interaction with viral glycoproteins E1 and E2 at the stage of HCV attachment and penetration into the cell. Data analysis was performed, including a two-stage scoring ranking of the identified candidate genes based on their interaction with basic genes and their presence in the results of network analysis of different web resources. Results. Candidate genes were initially identified using three web resources: HumanNet – 100 candidate genes, GeneMania – 20, STRING – 98. Based on the intersection of the three web resources, the total number of candidate genes associated with basic genes was 170. The total number of genes with a rank higher than 4 points was 35. Candidate genes were grouped into functional sets: cellular barriers and intercellular contacts (17 genes, 48.6%); lipid metabolism and lipoproteins (9 genes, 25.7%); immune response and interaction with the virus (5 genes, 14.3%); signaling pathways, proteolysis and cytoskeleton (4 genes, 11.4%). The following candidate genes potentially involved in the pathogenesis of HCV have been identified: APOA1, CLDN3, APOE, LIPC, LRPAP1, CSNK1E, APOB, CD19, CLDN6, CLDN9, ESAM, F11R, IFITM1, LDLRAP1, PCSK9, TJP1, CD9, CLDN11, CLDN17, CLDN2, CLDN5, IGSF8, MMP2, PDZK1, ADAM10, APOA2, C3, CLDN12, DAB1, GJB1, ITGB1, MYLIP, NEDD4L, PTGFRN. Conclusion. In the future, a detailed study of the functional features and polymorphic variants of the identified genes using bioinformatics and laboratory methods can significantly expand current understanding of the involvement of human genes in the development of HCV infection and discover new targets for the development of drugs and therapeutic strategies.